Decitabine Injection, Powder, Lyophilized, For Solution
Product Images NDC 68001-618

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Decitabine (NDC 68001-618). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Dec0b 0000 01)

Chemical structure of Decitabine, depicting its nucleoside composition with labeled atoms and characteristic molecular rings, consistent with the active ingredient Decitabine used in pharmaceutical formulations.*

FDA Label Image

Rev 0324 (Dec0b 0000 02)

Label for Decitabine for Injection, 50 mg per vial, a single-dose sterile vial for intravenous infusion only. The label includes a warning highlighting its cytotoxic agent status. Manufactured by QILU Pharmaceutical (Hainan) Co., Ltd. for BluePoint Laboratories. NDC 68001-618-37 and storage instructions are also provided.*

FDA Label Image

Rev 0225 (Decitabine For Injection 50mg Per Vial Label Rev 0225)

Label for Decitabine for Injection 50 mg per vial, a lyophilized powder for intravenous infusion. The label indicates it is a sterile, preservative-free, single-dose vial. Manufactured by Qilu Pharmaceutical (Hainan) Co., Ltd for BluePoint Laboratories. The label includes a warning identifying Decitabine as a cytotoxic agent.*

FDA Label Image

Rev 0324 (Image 01)

Carton label for Decitabine injection, powder, lyophilized for solution, 50 mg per vial, by BluePoint Laboratories. The label includes warnings about cytotoxic agents, storage instructions, and dosage form as a single-dose sterile vial. It is marked for intravenous infusion only and provides manufacturer information from Q.L.P. Pharmaceutical (Hainan) Co., Ltd.*

FDA Label Image

Rev 0225 (Decitabine For Injection 50mg Per Vial Carton Label Rev0225)

Carton label for Decitabine injection, lyophilized powder for solution, 50 mg per vial. The label indicates the product is for intravenous infusion only and is a cytotoxic agent. The label shows the BluePoint Laboratories logo and states that it is a single-dose sterile vial. Storage instructions and warnings about cytotoxicity are included. NDC 68001-618-37 is visible on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.